DB18622InvestigationalProtein Based Therapies
ABBV-011 is an antibody-drug conjugate of humanized, cysteine-engineered IgG1 monoclonal antibody targeting seizure-related 6 homolog conjugated to N-acetyl-gamma-calicheamicin.
- Mechanism
- Curator reviewed
Pharmacologically active on Seizure protein 6 homolog
- Also known as
- an antibody-drug conjugate of humanized, cysteine-engineered IgG1 monoclonal antibody targeting seizure-related 6 homolog conjugated to N-acetyl-gamma-calicheamicin
- Code names
- ABBV-011
Resolves to
Targets
What you can answer from here — as of July 09, 2026
Which drugs share a target with ABBV-011, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account